Non-Native Hawaiian Pacific Islanders (PI), defined as indigenous people having origins in Guam, the Commonwealth of the Northern Mariana Islands, American Samoa, Federated States of Micronesia, Republic of the Marshall Islands and Republic of Palau, have among the highest COVID-19-associated morbidity and mortality rates in the U.S. PI also suffer from medical co-morbidities known to increase their risk of severe COVID-19. In addition, PI have poor access to health care, inadequate or no health insurance, live in multi-generational or multi-family overcrowded housing, and have low-paying service jobs that expose them to the infected public. Hawaii is experiencing a dramatic surge in COVID-19, with triple-digit daily counts and more than 10,000 cases. PI, who comprise only 4% of the State?s population, account for 32% of COVID-19 cases. Our long-term goal is to reduce COVID-19 disparities among PI. The overall objective of the proposed research is to use culturally resonant community-engagement strategies to increase the reach and uptake of COVID-19 testing to better understand SARS-CoV-2 infection patterns among PI in Hawaii and on Guam. Our central hypothesis is that culturally appropriate and linguistically correct strategies will increase uptake of COVID-19 testing among PI, resulting in more precise SARS-CoV-2 infection and seroprevalence rates. Our multi-disciplinary investigative team comprises physicians and community health workers, community-engaged researchers and basic and applied scientists. The objective will be achieved by the following specific aims.
Specific Aim 1. Develop and evaluate culturally tailored community-engaged strategies to increase COVID-19 testing among PI in Hawaii and Guam. Approach: Engage PI communities to jointly design a strategy with culturally and linguistically appropriate content to promote COVID-19 testing and mplement the strategy and evaluate its effectiveness.
Specific Aim 2 : Determine SARS-CoV-2 infection patterns in asymptomatic PI in Hawaii and Guam. Approach: Perform COVID-19 RT-PCR and SARS-CoV-2-specific IgG and IgM testing of asymptomatic adult PI in Hawaii and Guam to ascertain infection rates and seroprevalence. A highly committed Community and Scientific Advisory Board, comprising prominent leaders in the PI community and academicians who are dedicated to improving IP health, will provide guidance to design culturally relevant strategies to mitigate COVID-19 disparities among PI. Strong support from the community, academia and government attest to the to the urgency of this Community-Engaged Testing Research Project.

Public Health Relevance

Non-Native Hawaiian Pacific Islanders (PI), who comprise only 4% of the State?s population, account for 32% of COVID-19 cases in Hawaii. PI are also disproportionately affected by COVID-19 on Guam, the westernmost U.S. Territory in the Pacific. Culturally relevant, community-engaged strategies are urgently needed to improve the reach and uptake of COVID-19 diagnostic testing to better understand SARS-CoV-2 infection patterns among PI in Hawaii and on Guam.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
3P30GM114737-05S1
Application #
10259631
Study Section
Special Emphasis Panel (ZMD1)
Program Officer
Caldwell, Sheila
Project Start
2020-11-17
Project End
2021-06-30
Budget Start
2020-11-17
Budget End
2021-06-30
Support Year
5
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Hawaii
Department
Pediatrics
Type
Schools of Medicine
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Medina, Liana O; To, Albert; Lieberman, Michael M et al. (2018) A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates. Front Immunol 9:2464
D'Antoni, Michelle L; Mitchell, Brooks I; McCurdy, Sara et al. (2018) Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression. J Leukoc Biol 104:1241-1252
Marciel, Michael P; Rose, Aaron H; Martinez, Verena et al. (2018) Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme. Cancer Med 7:175-183
Abanda, N N; DjieugouƩ, J Y; Khadka, V S et al. (2018) Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations. Clin Microbiol Infect 24:781.e1-781.e3
Guo, Mengjie; Lu, Sicheng; Huang, Hongming et al. (2018) Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer. BMC Syst Biol 12:118
Hynson, Nicole A; Frank, Kiana L; Alegado, Rosanna A et al. (2018) Synergy among Microbiota and Their Hosts: Leveraging the Hawaiian Archipelago and Local Collaborative Networks To Address Pressing Questions in Microbiome Research. mSystems 3:
Hu, Ling; Zhang, Rong; Yuan, Qiong et al. (2018) The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by A?25-35 triggered in SH-SY5Y cell. BMC Syst Biol 12:119
Jiang, Zhenhuan; Jiang, Jiannong; Zhao, Bizeng et al. (2018) CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells. Oncol Rep 39:643-650
Kim, Ji-Ae; Seong, Rak-Kyun; Kumar, Mukesh et al. (2018) Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models. Viruses 10:
Marciel, Michael P; Khadka, Vedbar S; Deng, Youpeng et al. (2018) Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis. Oncotarget 9:13407-13422

Showing the most recent 10 out of 65 publications